Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEN4GEN is a private Canadian genomics and molecular diagnostics company that provides commercial DNA testing, genetic testing, personalized and precision medicine services, and related genome research support. The company operates primarily as a diagnostics and services business rather than a therapeutic drug developer, offering a broad menu of clinical, consumer, and research-oriented genetic tests. Its offerings span hereditary disease testing, cancer-related genomics, prenatal and newborn testing, pharmacogenomics, forensic and relationship DNA testing, drug screening, and certain rapid-testing medical devices. CEN4GEN also markets itself as a provider of preventive and genome medicine services for patients, clinicians, researchers, and commercial entities. Based on currently available public information, it appears to be an active private healthcare company with commercial-stage service offerings and no disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEN4GEN Institute.